Update ESC-Leitlinien 2023 zum Management der infektiösen Endokarditis

Die infektiöse Endokarditis (IE) ist trotz wesentlicher Fortschritte in Diagnostik und Therapie seit Jahrzehnten eines der kardialen Erkrankungsbilder mit der schlechtesten Prognose bei einer durchschnittlichen Mortalität von 20–30% [1]. Dabei erfordert das Krankheitsbild einen interdisziplinären Diagnostik- und Therapieansatz, der ständigen Weiterentwicklungen unterliegt und im Leitlinien-Update 2023 in einigen Bereichen aktualisiert wurde.

Schlüsselwörter

nfektiöse Endokarditiis - Leitlinien - Update - Prävention - Diagnose - Therapie

• Literatur

• 1 Arjomandi Rad A, Tserioti E, Magouliotis DE. et al. The Surgical Treatment of Infective Endocarditis: A Comprehensive Review. Diagnostics (Basel) 2024; 14: 464
• 2 Delgado V, Ajmone Marsan N, de Waha S. et al. 2023 ESC Guidelines for the management of endocarditis. Eur Heart J 2023; 44: 3948-4042
• 3 Pries-Heje MM, Bundgaard H, Iversen KK. et al. Infective Endocarditis Antibiotic Prophylaxis: Review of the Evidence and Guidelines. Curr Cardiol Rep 2023; 25: 1873-1881
• 4 Diz Dios P, Monteiro L, Pimolbutr K. et al. World Workshop on Oral Medicine VIII: Dentists’ compliance with infective endocarditis prophylaxis guidelines for patients with high-risk cardiac conditions: a systematic review. Oral Surg Oral Med Oral Pathol Oral Radiol 2023; 135: 757-771
• 5 Lean SSH, Jou E, Ho JSY. et al. Prophylactic antibiotic use for infective endocarditis: a systematic review and meta-analysis. BMJ Open 2023; 13: e077026
• 6 Thornhill M, Prendergast B, Dayer M. et al. Endocarditis prevention: time for a review of NICE guidance. Lancet Reg Health Eur 2024; 39: 100876
• 7 Pries-Heje MM, Bundgaard H, Iversen KK. et al. Infective Endocarditis Antibiotic Prophylaxis: Review of the Evidence and Guidelines. Curr Cardiol Rep 2023; 25: 1873-1881
• 8 Luehr M, Weber C, Misfeld M. et al. Virulence of Staphylococcus Infection in Surgically Treated Patients With Endocarditis : A Multicenter Analysis. Ann Surg 2023; 277: e1364-e1372
• 9 El-Andari R, Fialka NM, Bozso SJ. et al. A multidisciplinary team approach to the long-term management of infective endocarditis: Complex management for complex patients. Int J Cardiol 2024; 404: 131936
• 10 Koch T, Hennigs A, Schmiedel S. Endocarditis guidelines: call for an interdisciplinary approach. Lancet Infect Dis 2024; 24: e75
• 11 Pries-Heje MM, Hjulmand JG, Lenz IT. et al. Clinical implementation of partial oral treatment in infective endocarditis: the Danish POETry study. Eur Heart J 2023; 44: 5095-5106
• 12 Squiers JJ, DiMaio JM, Banwait JK. et al. Surgical treatment of infective endocarditis at comprehensive versus primary valve centers. J Thorac Cardiovasc Surg 2023; 166: 442-452.e6
• 13 Luis Augusto BH, Maximiliano RA, José Alfredo AA. et al. Infective endocarditis complicated with heart failure. Eur J Intern Med 2024;
• 14 Spiliopoulos K, Magouliotis D, Xanthopoulos A. et al. Infective Endocarditis: Controversies and Convictions in the Surgical Treatment. Braz J Cardiovasc Surg 2023; 38: e20230014
• 15 Wang A. Reducing embolic events in left-sided infective endocarditis by surgery: the earlier the better. Eur Heart J 2023; 44: 4576-4578
• 16 Álvarez Zaballos S, Vazquez Alen P, Muñoz P. et al. Prevalence and Prognostic Impact of Stroke in a National Cohort of Infective Endocarditis. Int J Stroke 2024;
• 17 Lorenz V, Mastrobuoni S, Aphram G. et al. Tricuspid valve repair for infective endocarditis. Interdiscip Cardiovasc Thorac Surg 2024; 38: ivae084
• 18 Pokorney SD, Zepel L, Greiner MA. et al. Lead Extraction and Mortality Among Patients With Cardiac Implanted Electronic Device Infection. JAMA Cardiol 2023; 8: 1165-1173